Bipolar Disorder Therapeutics Market, Global Outlook and Forecast 2022-2028

April 2022 | 62 pages | ID: BFF7F93F70D1EN
Market Monitor Global

Abstracts

Bipolar disorder, also known as manic depression, is a mental disorder that could lead to periods of depression and elevated mood.

This report contains market size and forecasts of Bipolar Disorder Therapeutics in Global, including the following market information:

Global Bipolar Disorder Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Bipolar Disorder Therapeutics market was valued at 5202.1 million in 2021 and is projected to reach US$ 6466.9 million by 2028, at a CAGR of 3.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Mood Stabilizers Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Bipolar Disorder Therapeutics include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Astellas Pharma, Allergan, Johnson & Johnson, GlaxoSmithKline, AbbVie and Pfizer and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bipolar Disorder Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Bipolar Disorder Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Bipolar Disorder Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Mood Stabilizers
• Antipsychotic Drugs
• Antidepressant Drugs
• Other Drugs

Global Bipolar Disorder Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Bipolar Disorder Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Specialty Clinic
• Others

Global Bipolar Disorder Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Bipolar Disorder Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Bipolar Disorder Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Bipolar Disorder Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AstraZeneca
• Bristol-Myers Squibb
• Eli Lilly
• Astellas Pharma
• Allergan
• Johnson & Johnson
• GlaxoSmithKline
• AbbVie
• Pfizer
• Novartis

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Bipolar Disorder Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Bipolar Disorder Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BIPOLAR DISORDER THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Bipolar Disorder Therapeutics Market Size: 2021 VS 2028
2.2 Global Bipolar Disorder Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Bipolar Disorder Therapeutics Players in Global Market
3.2 Top Global Bipolar Disorder Therapeutics Companies Ranked by Revenue
3.3 Global Bipolar Disorder Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Bipolar Disorder Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Bipolar Disorder Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Bipolar Disorder Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Bipolar Disorder Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Bipolar Disorder Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Bipolar Disorder Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Mood Stabilizers
  4.1.3 Antipsychotic Drugs
  4.1.4 Antidepressant Drugs
  4.1.5 Other Drugs
4.2 By Type - Global Bipolar Disorder Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Bipolar Disorder Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Bipolar Disorder Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Bipolar Disorder Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Bipolar Disorder Therapeutics Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Specialty Clinic
  5.1.4 Others
5.2 By Application - Global Bipolar Disorder Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Bipolar Disorder Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Bipolar Disorder Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Bipolar Disorder Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Bipolar Disorder Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Bipolar Disorder Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Bipolar Disorder Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Bipolar Disorder Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Bipolar Disorder Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Bipolar Disorder Therapeutics Revenue, 2017-2028
  6.3.2 US Bipolar Disorder Therapeutics Market Size, 2017-2028
  6.3.3 Canada Bipolar Disorder Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Bipolar Disorder Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Bipolar Disorder Therapeutics Revenue, 2017-2028
  6.4.2 Germany Bipolar Disorder Therapeutics Market Size, 2017-2028
  6.4.3 France Bipolar Disorder Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Bipolar Disorder Therapeutics Market Size, 2017-2028
  6.4.5 Italy Bipolar Disorder Therapeutics Market Size, 2017-2028
  6.4.6 Russia Bipolar Disorder Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Bipolar Disorder Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Bipolar Disorder Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Bipolar Disorder Therapeutics Revenue, 2017-2028
  6.5.2 China Bipolar Disorder Therapeutics Market Size, 2017-2028
  6.5.3 Japan Bipolar Disorder Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Bipolar Disorder Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Bipolar Disorder Therapeutics Market Size, 2017-2028
  6.5.6 India Bipolar Disorder Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Bipolar Disorder Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Bipolar Disorder Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Bipolar Disorder Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Bipolar Disorder Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Bipolar Disorder Therapeutics Market Size, 2017-2028
  6.7.3 Israel Bipolar Disorder Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Bipolar Disorder Therapeutics Market Size, 2017-2028
  6.7.5 UAE Bipolar Disorder Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AstraZeneca
  7.1.1 AstraZeneca Corporate Summary
  7.1.2 AstraZeneca Business Overview
  7.1.3 AstraZeneca Bipolar Disorder Therapeutics Major Product Offerings
  7.1.4 AstraZeneca Bipolar Disorder Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 AstraZeneca Key News
7.2 Bristol-Myers Squibb
  7.2.1 Bristol-Myers Squibb Corporate Summary
  7.2.2 Bristol-Myers Squibb Business Overview
  7.2.3 Bristol-Myers Squibb Bipolar Disorder Therapeutics Major Product Offerings
  7.2.4 Bristol-Myers Squibb Bipolar Disorder Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Bristol-Myers Squibb Key News
7.3 Eli Lilly
  7.3.1 Eli Lilly Corporate Summary
  7.3.2 Eli Lilly Business Overview
  7.3.3 Eli Lilly Bipolar Disorder Therapeutics Major Product Offerings
  7.3.4 Eli Lilly Bipolar Disorder Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Eli Lilly Key News
7.4 Astellas Pharma
  7.4.1 Astellas Pharma Corporate Summary
  7.4.2 Astellas Pharma Business Overview
  7.4.3 Astellas Pharma Bipolar Disorder Therapeutics Major Product Offerings
  7.4.4 Astellas Pharma Bipolar Disorder Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Astellas Pharma Key News
7.5 Allergan
  7.5.1 Allergan Corporate Summary
  7.5.2 Allergan Business Overview
  7.5.3 Allergan Bipolar Disorder Therapeutics Major Product Offerings
  7.5.4 Allergan Bipolar Disorder Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Allergan Key News
7.6 Johnson & Johnson
  7.6.1 Johnson & Johnson Corporate Summary
  7.6.2 Johnson & Johnson Business Overview
  7.6.3 Johnson & Johnson Bipolar Disorder Therapeutics Major Product Offerings
  7.6.4 Johnson & Johnson Bipolar Disorder Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 Johnson & Johnson Key News
7.7 GlaxoSmithKline
  7.7.1 GlaxoSmithKline Corporate Summary
  7.7.2 GlaxoSmithKline Business Overview
  7.7.3 GlaxoSmithKline Bipolar Disorder Therapeutics Major Product Offerings
  7.7.4 GlaxoSmithKline Bipolar Disorder Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 GlaxoSmithKline Key News
7.8 AbbVie
  7.8.1 AbbVie Corporate Summary
  7.8.2 AbbVie Business Overview
  7.8.3 AbbVie Bipolar Disorder Therapeutics Major Product Offerings
  7.8.4 AbbVie Bipolar Disorder Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 AbbVie Key News
7.9 Pfizer
  7.9.1 Pfizer Corporate Summary
  7.9.2 Pfizer Business Overview
  7.9.3 Pfizer Bipolar Disorder Therapeutics Major Product Offerings
  7.9.4 Pfizer Bipolar Disorder Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 Pfizer Key News
7.10 Novartis
  7.10.1 Novartis Corporate Summary
  7.10.2 Novartis Business Overview
  7.10.3 Novartis Bipolar Disorder Therapeutics Major Product Offerings
  7.10.4 Novartis Bipolar Disorder Therapeutics Revenue in Global Market (2017-2022)
  7.10.5 Novartis Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Bipolar Disorder Therapeutics Market Opportunities & Trends in Global Market
Table 2. Bipolar Disorder Therapeutics Market Drivers in Global Market
Table 3. Bipolar Disorder Therapeutics Market Restraints in Global Market
Table 4. Key Players of Bipolar Disorder Therapeutics in Global Market
Table 5. Top Bipolar Disorder Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Bipolar Disorder Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Bipolar Disorder Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Bipolar Disorder Therapeutics Product Type
Table 9. List of Global Tier 1 Bipolar Disorder Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bipolar Disorder Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Bipolar Disorder Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Bipolar Disorder Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Bipolar Disorder Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Bipolar Disorder Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Bipolar Disorder Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Bipolar Disorder Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Bipolar Disorder Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Bipolar Disorder Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Bipolar Disorder Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Bipolar Disorder Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Bipolar Disorder Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Bipolar Disorder Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Bipolar Disorder Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Bipolar Disorder Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Bipolar Disorder Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Bipolar Disorder Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Bipolar Disorder Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Bipolar Disorder Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Bipolar Disorder Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. AstraZeneca Corporate Summary
Table 31. AstraZeneca Bipolar Disorder Therapeutics Product Offerings
Table 32. AstraZeneca Bipolar Disorder Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Bristol-Myers Squibb Corporate Summary
Table 34. Bristol-Myers Squibb Bipolar Disorder Therapeutics Product Offerings
Table 35. Bristol-Myers Squibb Bipolar Disorder Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Eli Lilly Corporate Summary
Table 37. Eli Lilly Bipolar Disorder Therapeutics Product Offerings
Table 38. Eli Lilly Bipolar Disorder Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Astellas Pharma Corporate Summary
Table 40. Astellas Pharma Bipolar Disorder Therapeutics Product Offerings
Table 41. Astellas Pharma Bipolar Disorder Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Allergan Corporate Summary
Table 43. Allergan Bipolar Disorder Therapeutics Product Offerings
Table 44. Allergan Bipolar Disorder Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Johnson & Johnson Corporate Summary
Table 46. Johnson & Johnson Bipolar Disorder Therapeutics Product Offerings
Table 47. Johnson & Johnson Bipolar Disorder Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. GlaxoSmithKline Corporate Summary
Table 49. GlaxoSmithKline Bipolar Disorder Therapeutics Product Offerings
Table 50. GlaxoSmithKline Bipolar Disorder Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. AbbVie Corporate Summary
Table 52. AbbVie Bipolar Disorder Therapeutics Product Offerings
Table 53. AbbVie Bipolar Disorder Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Pfizer Corporate Summary
Table 55. Pfizer Bipolar Disorder Therapeutics Product Offerings
Table 56. Pfizer Bipolar Disorder Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Novartis Corporate Summary
Table 58. Novartis Bipolar Disorder Therapeutics Product Offerings
Table 59. Novartis Bipolar Disorder Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Bipolar Disorder Therapeutics Segment by Type in 2021
Figure 2. Bipolar Disorder Therapeutics Segment by Application in 2021
Figure 3. Global Bipolar Disorder Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Bipolar Disorder Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Bipolar Disorder Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Bipolar Disorder Therapeutics Revenue in 2021
Figure 8. By Type - Global Bipolar Disorder Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Bipolar Disorder Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Bipolar Disorder Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Bipolar Disorder Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Bipolar Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Bipolar Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Bipolar Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Bipolar Disorder Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Bipolar Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Bipolar Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Bipolar Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Bipolar Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Bipolar Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Bipolar Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Bipolar Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Bipolar Disorder Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Bipolar Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Bipolar Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Bipolar Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Bipolar Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Bipolar Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Bipolar Disorder Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Bipolar Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Bipolar Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Bipolar Disorder Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Bipolar Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Bipolar Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Bipolar Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Bipolar Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. AstraZeneca Bipolar Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bristol-Myers Squibb Bipolar Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Eli Lilly Bipolar Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Astellas Pharma Bipolar Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Allergan Bipolar Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Johnson & Johnson Bipolar Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. GlaxoSmithKline Bipolar Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. AbbVie Bipolar Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Pfizer Bipolar Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Novartis Bipolar Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)